Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Cardiovascular Atherosclerosis Thrombosis Platelets

FITC Anti-Junctional Adhesion Molecule 1/JAM-A antibody [04] (ab275688)

FITC Anti-Junctional Adhesion Molecule 1/JAM-A antibody [04] (ab275688)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • FITC Mouse monoclonal [04] to Junctional Adhesion Molecule 1/JAM-A
  • Suitable for: Flow Cyt
  • Reacts with: Human
  • Conjugation: FITC. Ex: 493nm, Em: 528nm
  • Isotype: IgG1

You may also be interested in

Product image
CF405M Anti-CD9 antibody [VJ1/20] (ab123624)
Product image
Human CD31 Antibody Pair - BSA and Azide free (PECAM) (ab256599)
Product image
Anti-CD42a/GP-IX antibody [EP5294] (ab133573)
Product image
Anti-Syk antibody [SYK-01] (ab3993)

Overview

  • Product name

    FITC Anti-Junctional Adhesion Molecule 1/JAM-A antibody [04]
    See all Junctional Adhesion Molecule 1/JAM-A primary antibodies
  • Description

    FITC Mouse monoclonal [04] to Junctional Adhesion Molecule 1/JAM-A
  • Host species

    Mouse
  • Conjugation

    FITC. Ex: 493nm, Em: 528nm
  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    See all applications and species data
  • Immunogen

    Recombinant fragment (His-tag) corresponding to Human Junctional Adhesion Molecule 1/JAM-A aa 1-250 (extracellular). NP_058642.1. Polyhistidine tag at the C-terminus.
    Database link: Q9Y624

    Run BLAST with BLAST the sequence with ExPASy Run BLAST with BLAST the sequence with NCBI
  • Positive control

    • Flow Cyt: SK-BR-3 cells.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C. Do Not Freeze. Store In the Dark.
  • Storage buffer

    Preservative: 0.09% Sodium azide
    Constituent: 0.5% BSA
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    04
  • Isotype

    IgG1
  • Research areas

    • Cardiovascular
    • Blood
    • Platelets
    • Signal Transduction
    • Cytoskeleton / ECM
    • Cell Adhesion
    • Tight Junctions
    • Cardiovascular
    • Atherosclerosis
    • Vascular Inflammation
    • Leukocyte recruitment
    • Cell junction molecules

Images

  • Flow Cytometry - FITC Anti-Junctional Adhesion Molecule 1/JAM-A antibody [04] (ab275688)
    Flow Cytometry - FITC Anti-Junctional Adhesion Molecule 1/JAM-A antibody [04] (ab275688)

    Flow cytometric analysis of SK-BR-3 (human mammary gland adenocarcinoma cell line) cells labeling Junctional Adhesion Molecule 1/JAM-A with ab275688 at 10 μL per test (Black) compared to an isotype control (Grey).

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Syndecan-1 antibody [SP152] (ab130405)

  •  
  • Product image

    Anti-CRALBP antibody [EPR13801] (ab183728)

  •  
  • Product image

    Anti-TIM 3 antibody [EPR22285-13] (ab245941)

  •  
  • Product image

    Anti-CD28 antibody [CD28.2] - Low endotoxin, Azide free (ab85986)

  •  
  • Product image

    FITC Anti-CD4 antibody [GK1.5] (ab269349)

  •  
  • ML7, myosin light chain kinase inhibitor (ab120848)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.